ArticleNature communications2026
Context-aware sequence-to-function model of human gene regulation.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From reference-genome prediction to causal generalization: sequence-to-function models for plant regulatory genomics.Frontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sequence-to-function models have been very successful in predicting gene expression, chromatin accessibility, and epigenetic marks from DNA sequences alone. However, current state-of-the-art models have a fundamental limitation: they cannot extrapolate beyond the cell types and conditions included in their training dataset. Here, we introduce Corgi, a context-aware sequence-to-function model that overcomes this limitation by integrating DNA sequence and trans-regulator expression to predict chromatin accessibility, histone modifications, and gene expression coverage, even in held-out cell types. Trained on a diverse set of bulk and single-cell sequencing datasets, Corgi achieves top performance in joint cross-sequence and cross-cell-type epigenetic track prediction. Additionally, we present an advanced model version, Corgi+, which is state-of-the-art in imputation of epigenetic tracks using only RNA-seq data. We further show that Corgi learns key cell type-specific trans-regulators in a zero-shot manner, and it can predict genomic variant effects in held-out cell types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.